Catalyst Capital Advisors’s Medpace MEDP Stock Holding History

Catalyst Capital Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$543K	Sell	1,025 -165	-14%	-$76.1K	0.01%	167
2026 Q1	$571K	Hold	1,190	–	–	0.01%	161
2025 Q4	$668K	Hold	1,190	–	–	0.01%	162
2025 Q3	$612K	Sell	1,190 -190	-14%	-$83K	0.01%	168
2025 Q2	$433K	Hold	1,380	–	–	0.01%	190
2025 Q1	$420K	Sell	1,380 -610	-31%	-$205K	0.01%	190
2024 Q4	$661K	Hold	1,990	–	–	0.01%	181
2024 Q3	$664K	Sell	1,990 -160	-7%	-$60.8K	0.02%	174
2024 Q2	$885K	Buy	+2,150	New	+$851K	0.02%	154
2019 Q4	–	Sell	-80	Closed	-$7K	–	376
2019 Q3	$7K	Buy	+80	New	+$6.04K	﹤0.01%	371
2019 Q1	–	Sell	-45	Closed	-$2K	–	444
2018 Q4	$2K	Sell	45 -15	-25%	-$823	﹤0.01%	409
2018 Q3	$4K	Buy	+60	New	+$3.28K	﹤0.01%	422

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Catalyst Capital Advisors's MEDP Position: Q2 2026 in Review

Catalyst Capital Advisors reduced its Medpace (MEDP) stake by 14% in Q2 2026, selling an estimated $76.1K and leaving 1,025 shares worth $543K. The position accounts for 0.01% of the portfolio, ranked #167.

Catalyst Capital Advisors first reported a position in MEDP in Q3 2018 and has held it in 12 quarters since. The position peaked at $885K in Q2 2024. 696 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

Catalyst Capital Advisors held 1,025 shares of Medpace worth $543K as of Q2 2026.
Catalyst Capital Advisors sold 165 Medpace shares in Q2 2026, an estimated $76.1K.
Medpace made up 0.01% of Catalyst Capital Advisors's portfolio in Q2 2026, its #167 holding.
Catalyst Capital Advisors first reported a position in Medpace in Q3 2018 and has held it in 12 quarters since.
Catalyst Capital Advisors's Medpace position peaked at $885K in Q2 2024.
696 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Catalyst Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.